Publicacións (34) Publicacións de Julio Vázquez Rodríguez

2023

  1. Dose rate dependence study in MyQa SRS and its influence on gamma analysis.

    Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)

2016

  1. A single-institution analysis of the effect on local control of high-dose rate brachytherapy boost in a single 7 Gy fraction

    Revista de Senologia y Patologia Mamaria, Vol. 29, Núm. 2, pp. 63-68

  2. Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas

    Clinical Breast Cancer, Vol. 16, Núm. 4, pp. e83-e91

2015

  1. A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer

    OncoImmunology, Vol. 4, Núm. 7, pp. 1-11

2012

  1. Gastrointestinal stromal tumor arising in the rectovaginal septum

    Journal of Lower Genital Tract Disease, Vol. 16, Núm. 2, pp. 158-161

  2. SU‐E‐T‐388: Verification of Monitor Units and Dose Distributions in IMRT Plans Using Monte Carlo Algorithms on the E‐IMRT Web Platform

    Medical Physics

2009

  1. Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas

    Breast Cancer Research and Treatment, Vol. 116, Núm. 1, pp. 39-52

  2. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma

    Human Pathology, Vol. 40, Núm. 9, pp. 1224-1233

  3. From the limits of the classical model of sensitometric curves to a realistic model based on the percolation theory for GafChromic EBT films

    Medical Physics, Vol. 36, Núm. 9, pp. 4015-4026

2008

  1. Androgen receptor expresion in breast cancer: Relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors

    BMC Cancer, Vol. 8

  2. Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast

    Histopathology, Vol. 53, Núm. 4, pp. 403-415

  3. The mammographic appearance of breast carcinomas of invasive ductal type: Relationship with clinicopathological parameters, biological features and prognosis

    European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 136, Núm. 2, pp. 224-231

2007

  1. Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse

    British Journal of Cancer, Vol. 97, Núm. 7, pp. 957-963

  2. Study of matrix metalloproteinases and their inhibitors in breast cancer

    British Journal of Cancer, Vol. 96, Núm. 6, pp. 903-911

2006

  1. Cytosolic levels of TFF1/pS2 in breast cancer: Their relationship with clinical-pathological parameters and their prognostic significance

    Breast Cancer Research and Treatment, Vol. 96, Núm. 1, pp. 63-72

2005

  1. Clinical significance of cathepsin D concentration in tumor cytosol of primary breast cancer

    International Journal of Biological Markers, Vol. 20, Núm. 2, pp. 103-111

  2. Clinical significance of the quantitative assessment of the cytosolic concentration of HER-2/neu protein in breast cancer by immunoenzymatic assay (ELISA)

    Journal of Cancer Research and Clinical Oncology, Vol. 131, Núm. 11, pp. 701-714

  3. Expression and prognostic value of EGFR in invasive breast cancer

    Oncology Reports, Vol. 14, Núm. 6, pp. 1655-1663

  4. Pronóstico del cáncer de cérvix en un hospital de área

    Progresos de Obstetricia y Ginecologia, Vol. 48, Núm. 10, pp. 473-479

  5. Tissue-Type plasminogen activator (tPA) in breast cancer: Relationship with clinicopathological parameters and prognostic significance

    Breast Cancer Research and Treatment, Vol. 90, Núm. 1, pp. 33-40